Turnover: 7.5 million EUR (2022)
Country: France
- Mauna Kea manufactures and distributes medical imaging equipment.
- Since its creation in 2000, Mauna Kea has specialized in the design, manufacture and distribution of in vivo digital endomicroscopy equipment.
- The technology developed by the company enables real-time imaging at cellular level. This makes Cellvizio a particularly sought-after product for its optical cutting capability, which can have applications in surgery and medicine.
- Mauna Kea is listed on the stock exchange, and its main shareholders are : - Inocap gestion (4.5%) - Bellevue Asset Management (3%) - FORUM Family Office Services (2.2%).
Financial Data
DUNS: 431268028
Legal Name: MAUNA KEA TECHNOLOGIES
Address: 9 RUE D ENGHIEN , 75010 PARIS 10
Number of employees: Entre 50 et 99 salariés (2021)
Capital: 2 464 410 EUR
Financial Data:
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5 332 370 | 6 992 787 | 4 403 044 | 6 632 370 | 8 338 448 | 6 287 244 | 7 331 438 | 7 368 575 | 11 655 908 |
| Gross margin (€) | 5 342 252 | 6 582 114 | 4 252 331 | 6 919 131 | 7 050 862 | 5 416 563 | 5 732 064 | 6 565 898 | 109 226 211 |
| EBITDA (€) | -6 495 482 | -7 196 725 | -9 285 615 | -8 771 903 | -6 504 041 | -6 609 461 | -7 153 047 | -9 052 217 | -7 368 551 |
| Operating profit (€) | -6 815 581 | -7 092 654 | -9 399 982 | -8 100 728 | -7 056 436 | -6 922 842 | -7 970 451 | -9 298 273 | -7 858 417 |
| Net profit (€) | -12 876 699 | -16 033 906 | -9 444 555 | -15 534 771 | -11 871 126 | -3 982 200 | -10 610 123 | -15 424 674 | -14 741 711 |
| Turnover growth rate (%) | -23,7 | 58,8 | -33,6 | -20,5 | 32,6 | -14,2 | -0,5 | -36,8 | - |
| Ebitda margin rate (%) | -121,8 | -102,9 | -210,9 | -132,3 | -78 | -105,1 | -97,6 | -122,8 | -63,2 |
| Operating margin rate (%) | -127,8 | -101,4 | -213,5 | -122,1 | -84,6 | -110,1 | -108,7 | -126,2 | -67,4 |
| Working Capital (turnover days) | 112,4 | 25 | 57,6 | 120,9 | 162,8 | 221,7 | 104,4 | 164,7 | 94,5 |
| Working Capital requirements (turnover days) | 619,1 | 76,7 | 179,2 | 158,4 | 105,6 | 174,8 | 56,4 | 185,6 | 104,3 |
| Net margin (%) | -241,5 | -229,3 | -214,5 | -234,2 | -142,4 | -63,3 | -144,7 | -209,3 | -126,5 |
| Added value / Turnover (%) | -0,1 | 7,8 | -37,1 | -8,6 | 10 | 4,1 | -0,4 | -5,6 | 16 |
| Wages and social charges (€) | 6 379 682 | 7 140 765 | 7 240 741 | 7 032 172 | 7 031 321 | 6 577 628 | 6 733 803 | 8 505 745 | 9 027 686 |
| Salaries / Turnover (%) | 119,6 | 102,1 | 164,4 | 106 | 84,3 | 104,6 | 91,8 | 115,4 | 77,5 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Administrateur | Molly | O'neill | 60 | |
| Administrateur | Christopher | Mcfadden | 56 | |
| Administrateur | Claire | Biot | 41 | |
| Administrateur | Jacquelien | Ten Dam | 41 | |
| Autre | Alexandre | Loiseau | 54 |
Studies mentioning this company
The medical imaging market - France
Other companies mentioned:
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.